-
Loading metrics
Open Access
Peer-reviewed
Research Article
Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals
-
Cheryl A. Stoddart ,
*To whom correspondence should be addressed. E-mail: cheryl.stoddart@ucsf.edu
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Cheryl A. Bales,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Jennifer C. Bare,
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
George Chkhenkeli,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Sofiya A. Galkina,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
April N. Kinkade,
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Mary E. Moreno,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
José M. Rivera,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Rollie E. Ronquillo,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Barbara Sloan,
Current address: Division of Experimental Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California, United States of America
Affiliation Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, United States of America
⨯ -
Paul L. Black
Affiliation Targeted Interventions Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals
- Cheryl A. Stoddart,
- Cheryl A. Bales,
- Jennifer C. Bare,
- George Chkhenkeli,
- Sofiya A. Galkina,
- April N. Kinkade,
- Mary E. Moreno,
- José M. Rivera,
- Rollie E. Ronquillo,
- Barbara Sloan
- Published: August 1, 2007
- https://doi.org/10.1371/journal.pone.0000655